What is the treatment for Tinea pedis (athlete's foot)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Pedis

For interdigital tinea pedis, apply topical terbinafine 1% cream twice daily for 1 week, which provides superior efficacy compared to 4 weeks of other topical antifungals and is the recommended first-line treatment. 1, 2, 3

First-Line Topical Therapy

Terbinafine 1% cream is the preferred initial treatment due to its fungicidal mechanism and shorter treatment duration 1, 2:

  • For interdigital tinea pedis (between the toes): Apply twice daily for 1 week 1, 3
  • For plantar tinea pedis (bottom or sides of foot): Apply twice daily for 2 weeks 3
  • Achieves 93.5% mycological cure rate at 4 weeks and 89.7% effective treatment rate, significantly superior to clotrimazole 4
  • FDA-approved for patients 12 years and older 3

Alternative Topical Agents

If terbinafine is unavailable or contraindicated, consider these options:

  • Ciclopirox olamine 0.77% cream/gel: Apply twice daily for 4 weeks, achieving 60% cure at treatment end and 85% two weeks post-treatment 1, 2
  • Clotrimazole 1% cream: Apply twice daily for 4 weeks, though less effective than terbinafine (73% mycological cure vs 93.5%) 1, 4

Oral Therapy for Severe or Resistant Cases

Reserve systemic treatment for extensive disease, failed topical therapy, concomitant onychomycosis, or immunocompromised patients 2, 5:

  • Oral terbinafine 250 mg once daily for 1 week: Provides similar mycological efficacy to 4 weeks of topical clotrimazole but with faster clinical resolution 1, 2
  • Oral itraconazole 100 mg daily for 2 weeks: Similar efficacy to oral terbinafine but may have slightly higher relapse rates 1, 2

Important Safety Considerations

  • Monitor for rare but serious adverse events with oral terbinafine, including isolated neutropenia and liver failure, particularly in patients with preexisting liver disease 1, 5

Prevention Strategies

Implement these measures to reduce recurrence and transmission 1, 2:

  • Apply foot powder after bathing (reduces infection rates from 8.5% to 2.1%) 1, 2
  • Thoroughly dry between toes after showering 1, 2
  • Change socks daily 1, 2
  • Periodically clean athletic footwear 1, 2
  • Cover active foot lesions with socks before wearing underwear to prevent spread to groin 1, 2

Common Pitfalls to Avoid

  • Failing to treat all infected family members simultaneously can result in reinfection 2
  • Neglecting contaminated footwear as a source of reinfection leads to recurrence 2
  • Stopping treatment based on clinical improvement alone rather than mycological cure increases relapse risk 5
  • Not examining other body sites (hands, groin, body folds) when diagnosing tinea pedis, as dermatophytes commonly cause concomitant infections at multiple sites 2

Risk Factors to Consider

Patients at higher risk for tinea pedis include 1, 5:

  • Swimmers and runners (up to 22% infection rate in marathon runners) 1
  • Males (more commonly affected than females) 1
  • Those with obesity or diabetes 1, 5
  • Individuals exposed to warm, humid environments 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Tinea Corporis and Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.